Evidence map›Paper›PMID 24968937›Full record

ArticleScience (New York, N.Y.)2014

HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.

F Maldarelli, X Wu, L Su, F R Simonetti, W Shao, S Hill, J Spindler, A L Ferris, J W Mellors, M F Kearney and 2 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 628 papers.

0numbers the graph read from it
0cells of the map it votes in
628citing papers in PubMed
34.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

628 citing papers in PubMed, 888 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Manipulation of the cell cycle by HIV-1.Biochemical Society transactions · 2026
    Review
  5. Review
  6. Molecular therapy. Nucleic acids · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The HIV reservoir landscape in elite controllers.Current opinion in HIV and AIDS · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

568 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

F MaldarelliHIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702, USA.
X WuLeidos Biomedical Research, Frederick, MD 21702, USA.
L SuLeidos Biomedical Research, Frederick, MD 21702, USA.
F R SimonettiHIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702, USA. Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, 20122 Milan, Italy.
W ShaoLeidos Biomedical Research, Frederick, MD 21702, USA.
S HillHIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702, USA.
J SpindlerHIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702, USA.
A L FerrisHIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702, USA.
J W MellorsDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
M F KearneyHIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702, USA.
J M CoffinDepartment of Molecular Biology and Microbiology, Tufts University, Boston, MA 02111, USA.
S H HughesHIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702, USA. hughesst@mail.nih.gov.
National Cancer Institute · USLeidos Biomedical Research Inc. (United States)Leidos (United States) · USTufts University · USUniversity of Pittsburgh · US

Funding

IntegraseZIABC011426 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HUGHES, STEPHEN H · 2012 to 2022
$14.0M
Retrovirus EvolutionR37CA089441 · NCI · TUFTS UNIVERSITY BOSTON · PI COFFIN, JOHN M · 2006 to 2015
$6.5M
RETROVIRUS EVOLUTIONR01CA089441 · NCI · TUFTS UNIVERSITY BOSTON · PI COFFIN, JOHN M · 2001 to 2005
$3.0M
Intramural NIH HHS Z99 CA999999NCI NIH HHS R01 CA089441NCI NIH HHS R37 CA089441PHS HHS 25XS119PHS HHS HSSN261200800001E
6 · The paper itself

Abstract

The persistence of HIV-infected cells in individuals on suppressive combination antiretroviral therapy (cART) presents a major barrier for curing HIV infections. HIV integrates its DNA into many sites in the host genome; we identified 2410 integration sites in peripheral blood lymphocytes of five infected individuals on cART. About 40% of the integrations were in clonally expanded cells. Approximately 50% of the infected cells in one patient were from a single clone, and some clones persisted for many years. There were multiple independent integrations in several genes, including MKL2 and BACH2; many of these integrations were in clonally expanded cells. Our findings show that HIV integration sites can play a critical role in expansion and persistence of HIV-infected cells.

Indexed as

Anti-Retroviral AgentsBasic-Leucine Zipper Transcription FactorsClone CellsDNA, ViralGenome, HumanHIVHIV InfectionsHumansRNA, ViralTranscription FactorsVirus IntegrationVirus LatencyAnti-Retroviral AgentsBACH2 protein, humanBasic-Leucine Zipper Transcription FactorsDNA, ViralMRTFB protein, humanRNA, ViralTranscription Factors

Identifiers

PMID24968937
PMCPMC4262401
OpenAlexW2114538357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.